Avenue Therapeutics
menu
  • About
    • Management Team
    • Board of Directors
  • Pipeline
    • BAER-101
    • IV Tramadol
    • AJ201
  • Publications
  • Investors
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
      • Analyst Coverage
    • Stock Data
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Events
  • Contact Us
    • Careers
      • Email Alerts

Press Releases

Investors

Investors

  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Analyst Coverage
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
May 11, 2020

Avenue Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate Highlights

Apr 23, 2020

Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters

Mar 30, 2020

Avenue Therapeutics Reports Full Year 2019 Financial Results and Recent Corporate Highlights

Feb 13, 2020

Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for Review by FDA

Dec 11, 2019

Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol

Nov 04, 2019

Avenue Therapeutics Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Oct 28, 2019

Avenue Therapeutics Announces Publication of IV Tramadol Phase 1 Clinical Data in Clinical Pharmacology in Drug Development

Oct 18, 2019

Avenue Therapeutics to Present Phase 3 Bunionectomy Study of IV Tramadol at the American Society of Anesthesiologists Annual Meeting

Aug 14, 2019

Avenue Therapeutics Reports Second Quarter 2019 Financial Results and Recent Corporate Highlights

Aug 01, 2019

Avenue Therapeutics Announces Appointment of Ms. E. Garrett Ingram to Board of Directors

  • arrow_back
  • 1…
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
  • Privacy
  • Disclaimer
  • Contact Us


twitter icon linked-in icon
Website Design, Maintenance and Hosting by Tidal Media Group
Copyright ©2025 Avenue Therapeutics.

logo